Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 18;12(2):241.
doi: 10.3390/healthcare12020241.

Real-World Dispensing of Buprenorphine in California during Prepandemic and Pandemic Periods

Yun Wang  1 , Alexandre Chan  2 , Richard Beuttler  1 , Marc L Fleming  1 , Todd Schneberk  3 , Michael Nichol  4 , Haibing Lu  5
Affiliations

Real-World Dispensing of Buprenorphine in California during Prepandemic and Pandemic Periods

Yun Wang et al. Healthcare (Basel). .

Abstract

Introduction: The opioid overdose crisis in the United States has become a significant national emergency. Buprenorphine, a primary medication for individuals coping with opioid use disorder (OUD), presents promising pharmacokinetic properties for use in primary care settings, and is often delivered as a take-home therapy. The COVID-19 pandemic exacerbated the scarcity of access to buprenorphine, leading to dire consequences for those with OUD. Most existing studies, primarily focused on the immediate aftermath of the COVID-19 outbreak, highlight the challenges in accessing medications for opioid use disorder (MOUDs), particularly buprenorphine. However, these studies only cover a relatively short timeframe.

Methods: To bridge this research gap, in our study, we utilized 33 months of California's prescription drug monitoring program (PDMP) data to provide insights into real-world buprenorphine dispensing trends since the onset of the pandemic from 2018 to 2021, focusing on outcomes such as patient counts, prescription volumes, prescriber involvement, days' supply, and dosage. Statistical analysis employed interrupted time series analysis to measure changes in trends before and during the pandemic.

Results: We found no significant impact on patient counts or prescription volumes during the pandemic, although it impeded the upward trajectory of prescriber numbers that was evident prior to the onset of the pandemic. An immediate increase in days' supply per prescription was observed post-pandemic.

Conclusion: Our findings differ in comparison to previous data regarding the raw monthly count of patients and prescriptions. The analysis encompassed uninsured patients, offering a comprehensive perspective on buprenorphine prescribing in California. Our study's insights contribute to understanding the impact of COVID-19 on buprenorphine access, emphasizing the need for policy adjustments.

Keywords: COVID-19; buprenorphine; healthcare access; opioid use disorder; opioids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Monthly counts of patients, prescribers, and prescriptions from March 2019 to December 2021. The vertical line in the figures indicates the start of the COVID-19 pandemic.
Figure 1
Figure 1
Monthly counts of patients, prescribers, and prescriptions from March 2019 to December 2021. The vertical line in the figures indicates the start of the COVID-19 pandemic.
See this image and copyright information in PMC

References

    1. McCartney M. The fall of a poisoned empire. Lancet. 2022;399:135. doi: 10.1016/S0140-6736(21)02839-7. - DOI
    1. Slavova S., Rock P., Bush H.M., Quesinberry D., Walsh S.L. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend. 2020;214:108176. - PMC - PubMed
    1. Rodda L.N., West K.L., LeSaint K.T. Opioid overdose–related emergency department visits and accidental deaths during the COVID-19 pandemic. J. Urban Health. 2020;97:808–813. - PMC - PubMed
    1. National Vital Statistics System Provisional Drug Overdose Death Counts. [(accessed on 1 September 2023)]; Available online: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
    1. California Department of Health Care Services California Response to the Overdose Crisis. [(accessed on 1 September 2023)]. Available online: https://www.californiamat.org/wp-content/uploads/2020/05/MAT_Flyers_DHCS....